UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3352) 3352
covid-19 (3205) 3205
sars-cov-2 (2916) 2916
science & technology (2820) 2820
life sciences & biomedicine (2658) 2658
pandemics (2356) 2356
betacoronavirus - pathogenicity (2090) 2090
coronaviruses (1505) 1505
coronavirus infections - virology (1342) 1342
pneumonia, viral - virology (1339) 1339
coronavirus infections - epidemiology (1142) 1142
pneumonia, viral - epidemiology (1116) 1116
severe acute respiratory syndrome coronavirus 2 (981) 981
female (951) 951
male (946) 946
sars-cov-2 - pathogenicity (763) 763
coronavirus infections - diagnosis (734) 734
pneumonia, viral - diagnosis (699) 699
middle aged (665) 665
severe acute respiratory syndrome (614) 614
coronavirus infections - transmission (608) 608
adult (599) 599
pneumonia, viral - transmission (598) 598
pandemics - prevention & control (593) 593
viral diseases (575) 575
covid-19 - virology (558) 558
coronavirus infections - prevention & control (546) 546
aged (529) 529
health aspects (522) 522
pneumonia, viral - prevention & control (522) 522
viruses (473) 473
animals (472) 472
infections (439) 439
coronavirus (431) 431
risk factors (429) 429
coronavirus infections - immunology (425) 425
pneumonia, viral - immunology (416) 416
epidemics (406) 406
immunology (399) 399
coronavirus infections - complications (397) 397
pneumonia, viral - complications (396) 396
coronavirus infections - therapy (380) 380
infectious diseases (376) 376
pneumonia, viral - therapy (372) 372
disease transmission (370) 370
severity of illness index (370) 370
betacoronavirus - immunology (338) 338
coronavirus infections - drug therapy (320) 320
betacoronavirus - genetics (317) 317
review (313) 313
covid-19 - epidemiology (304) 304
pneumonia, viral - drug therapy (304) 304
pneumonia, viral - pathology (302) 302
respiratory diseases (301) 301
coronavirus infections - pathology (300) 300
public health (288) 288
medicine, research & experimental (280) 280
research & experimental medicine (280) 280
betacoronavirus - isolation & purification (278) 278
biochemistry & molecular biology (267) 267
virology (258) 258
abridged index medicus (253) 253
vaccines (248) 248
covid-19 testing (246) 246
epidemiology (243) 243
mortality (241) 241
patients (239) 239
proteins (238) 238
medical research (230) 230
microbiology (230) 230
china - epidemiology (229) 229
coronavirus infections - mortality (228) 228
antiviral agents - therapeutic use (226) 226
cell biology (226) 226
pneumonia, viral - mortality (223) 223
pneumonia, viral - physiopathology (223) 223
coronavirus infections - physiopathology (222) 222
angiotensin-converting enzyme 2 (221) 221
host-pathogen interactions (221) 221
retrospective studies (221) 221
aged, 80 and over (220) 220
betacoronavirus - drug effects (219) 219
covid‐19 (219) 219
analysis (201) 201
pneumonia (200) 200
treatment outcome (196) 196
prognosis (190) 190
inflammation (186) 186
adolescent (181) 181
general & internal medicine (179) 179
neurosciences & neurology (179) 179
time factors (176) 176
risk assessment (174) 174
cardiovascular system & cardiology (173) 173
covid-19 - drug therapy (173) 173
lung - virology (164) 164
medicine, experimental (164) 164
comorbidity (163) 163
betacoronavirus - physiology (159) 159
covid-19 - diagnosis (159) 159
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3564) 3564
Chinese (25) 25
French (13) 13
Spanish (11) 11
Russian (7) 7
Icelandic (4) 4
Italian (4) 4
Arabic (2) 2
German (2) 2
Portuguese (2) 2
Korean (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 0028-0836, 07/2020, Volume 583, Issue 7818, pp. 830 - 833
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Betacoronavirus - pathogenicity | Bronchi - virology | Antigens, Viral - metabolism | Pandemics | Humans | Male | Betacoronavirus - immunology | COVID-19 | Peptidyl-Dipeptidase A - genetics | Lung - virology | SARS-CoV-2 | Lymphocytes - immunology | Immunoglobulin G - immunology | Receptors, Complement 3d - genetics | Peptidyl-Dipeptidase A - metabolism | Female | Transgenes | Bronchi - pathology | Macrophages, Alveolar - immunology | Disease Models, Animal | Macrophages, Alveolar - virology | Lung - pathology | Pneumonia, Viral - pathology | Epithelial Cells - pathology | Mice, Transgenic | Betacoronavirus - metabolism | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Angiotensin-Converting Enzyme 2 | Antigens, Viral - immunology | Animals | Coronavirus Infections - virology | Virus Replication | Weight Loss | Epithelial Cells - virology | Coronavirus Infections - pathology | Mice | Receptors, Complement 3d - metabolism | Pneumonia, Viral - virology | Lung - immunology | Genetically modified mice | Genetic aspects | Analysis | Viroids | Angiotensin converting enzyme | Pneumonia | Pathogenesis | Epithelial cells | Viral diseases | Viruses | Infections | Vaccines | Macrophages | Angiotensin-converting enzyme 2--ACE2 | Histopathology | Peptidyl-dipeptidase A | Lymphocytes | Transgenic animals | Rodents | Alveoli | Public health | Antigens | Pathogens | Severe acute respiratory syndrome | Neutrophils | Weight loss | Transgenic mice | Pharmacology | Coronaviruses | Chemical compounds | Severe acute respiratory syndrome coronavirus 2 | Pathogenicity | Lungs | Respiratory diseases | Angiotensin | Fatalities | Index Medicus
Journal Article
by Nascimento, Fabricia F and Colquhoun, Rachel M and Shepherd, James and Koshy, Cherian and Wise, Emma and Curran, Tanya and Adams, Helen and Moore, Catrin and Reynolds, Nicola and Afifi, Safiah and Price, Anna and Kitchen, Christine and Merrick, Ian and Bresner, Catherine and Robson, Samuel C and Loveson, Katie F and Taylor, Ben E.W and Menegazzo, Mirko and Clark, Gemma and Bird, Paul and Helmer, Thomas and Fallon, Karlie and Loose, Matthew W and du Plessis, Louis and Attwood, Stephen and Vasylyeva, Tetyana and Goodfellow, Ian G and Chaudhry, Yasmin and Moses, Samuel and Ryan, Felicity and Brown, Julianne Rose and Alcolea-Medina, Adela and Moore, Nathan and Cortes, Nicholas and Williams, Rebecca and Chapman, Michael R and Smith, Darren L and Holmes, Alison and Price, James and Rowan, Aileen and Watts, Joanne and Ludden, Catherine and Niebel, Marc O and Li, Kathy K and Johnson, Natasha and Robertson, David L and Eltringham, Gary and Barton, Edward and Scott, Garren and Yew, Wen C and Justice, Anita and Pymont, Hannah M and Chand, Meera and Harrison, Ian and Chalker, Vicki and Heyburn, David and Downing, Fatima and Watkins, Joanne and Howe, Robin and Wain, John and Mather, Alison E and Rudder, Steven and Alikhan, Nabil-Fareed and Kingsley, Robert A and Casey, Anna and Mahungu, Tabitha W and Liggett, Steven and Findlay, Jacqueline and Beggs, Andrew and Smith, Colin P and Churcher, Carol M and Bellis, Katherine L and Girgis, Sophia T and Kermack, Leanne M and Aggarwal, Dinesh and Davidson, Rose K and Gallagher, Michael D and Colquhoun, Rachel and Ashworth, Jordan and Michelsen, Michelle L and Darby, Alistair C and Vamos, Edith E and Hughes, Margaret and Rainbow, Lucille and Parsons, Paul J and Bridgewater, Hannah E and McClure, Patrick C and Jackson, David K and Quail, Mike and Thurston, Scott and Beaver, Charlotte and McMinn, Liz and Puethe, Christoph and Tonkin-Hill, Gerry and Smith, Christen and Jamrozy, Dorota and Beale, Mathew A and Patel, Minal and Drury, Eleanor and Buddenborg, Sarah K and COG-UK Consortium
Cell (Cambridge), ISSN 0092-8674, 01/2021, Volume 184, Issue 1, pp. 64 - 75.e11
Journal Article
Journal Article
IUBMB life, ISSN 1521-6543, 10/2020, Volume 72, Issue 10, pp. 2097 - 2111
antibiotic | viral infection | COVID‐19 | SARS‐CoV‐2 | bacterial co‐infection | COVID-19 | bacterial co-infection | SARS-CoV-2 | Respiratory System - pathology | Coinfection | Klebsiella pneumoniae - drug effects | Pandemics | Haemophilus influenzae - drug effects | Humans | Respiratory System - microbiology | Host-Pathogen Interactions - immunology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Respiratory System - virology | Bacterial Infections - virology | Streptococcus pyogenes - pathogenicity | Streptococcus pneumoniae - pathogenicity | Pseudomonas aeruginosa - pathogenicity | SARS-CoV-2 - drug effects | COVID-19 - epidemiology | Legionella pneumophila - pathogenicity | Bacterial Infections - microbiology | COVID-19 - virology | Pneumonia, Bacterial - microbiology | Streptococcus pneumoniae - drug effects | Streptococcus pyogenes - drug effects | Immunity, Innate - drug effects | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Acinetobacter baumannii - pathogenicity | Legionella pneumophila - drug effects | Pneumonia, Bacterial - epidemiology | Pneumonia, Bacterial - virology | Pseudomonas aeruginosa - drug effects | COVID-19 - drug therapy | SARS-CoV-2 - pathogenicity | COVID-19 - microbiology | Klebsiella pneumoniae - pathogenicity | Bacterial Infections - epidemiology | Respiratory System - drug effects | Pneumonia, Bacterial - drug therapy | Acinetobacter baumannii - drug effects | Haemophilus influenzae - pathogenicity | Bacterial infections | Mortality | Azithromycin | Infections | Coronaviruses | Risk factors | Severe acute respiratory syndrome coronavirus 2 | Antibiotics | Influenza | Bacteria | Viral infections | Index Medicus
Journal Article